Dr. Peguero Participates in Two Posters at ASCO

Dr. Julio Peguero, OC's Research Department Director, participated in two posters ASCO. Click on the links below to view the posters:

Genomic Mutation Profiling and Clinical Outcome in Patients Treated With Ribociclib (CDK4/6 inhibitor) in the Signature Program

Prevention of Everolimus/Exemestane Stomatitis in Postmenopausal Women With Hormone Receptor–Positive Metastatic Breast Cancer Using a Dexamethasone-Based Mouthwash: Results of the SWISH Trial

#Research